Common use

Lenalidomide is a potent immunomodulatory agent prescribed for the treatment of multiple myeloma, myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality, and certain types of non-Hodgkin lymphoma, including mantle cell lymphoma. As a thalidomide analogue, lenalidomide works through multiple mechanisms of action: it suppresses abnormal cancer cell proliferation, enhances the immune system’s ability to recognize and attack malignant cells through T-cell and natural killer cell activation, inhibits angiogenesis (the formation of new blood vessels that supply nutrients to growing tumors), and modulates the tumor microenvironment. This multi-targeted approach has made lenalidomide a cornerstone of modern myeloma therapy, often used in combination with dexamethasone or other chemotherapy agents. Buy lenalidomide online at DutyPills for affordable access to this essential cancer treatment medication.

Dosage and direction

Lenalidomide capsules are taken orally, usually once daily at the same time each day, with or without food, as directed by your oncologist or hematologist. Swallow the capsules whole with a full glass of water; do not open, crush, break, or chew them. The specific dosage depends on the type and stage of your condition, kidney function, body weight, and your individual response to therapy. Treatment for multiple myeloma typically follows a cyclical schedule, with periods of active dosing followed by rest days. Your healthcare team will perform regular blood count monitoring (complete blood count with differential), kidney function tests, and other laboratory assessments throughout your treatment to adjust the dose as needed and ensure safety.

Precautions

Before starting lenalidomide therapy, inform your doctor about any pre-existing kidney or liver disease, a personal or family history of blood clots (deep vein thrombosis or pulmonary embolism), cardiovascular conditions, active infections, or immunodeficiency. Lenalidomide is classified as a known human teratogen and can cause severe, life-threatening birth defects. Therefore, strict pregnancy prevention measures are mandatory: women of childbearing potential must use two reliable forms of contraception beginning four weeks before treatment, throughout therapy, and for at least four weeks after discontinuation. Men taking lenalidomide must also use barrier contraception. Avoid exposure to people with active infections, as this medication can suppress your immune system. Report any signs of infection such as fever, sore throat, or unusual fatigue to your doctor promptly.

Contraindications

Do not use lenalidomide if you are allergic to it, to thalidomide, or to any of its inactive ingredients. Lenalidomide is strictly contraindicated during pregnancy and breastfeeding due to the extremely high risk of severe fetal malformations and embryo-fetal death. Women must have a confirmed negative pregnancy test before initiating treatment. Patients who cannot comply with the mandatory risk management program (REMS) requirements should not receive this medication.

Possible side effect

Common side effects of lenalidomide include fatigue, diarrhea, constipation, nausea, skin rash, muscle cramps, decreased appetite, and reduced blood cell counts (neutropenia, thrombocytopenia, anemia). Because the drug affects bone marrow function, regular hematologic monitoring is essential. More serious side effects may include an increased risk of venous and arterial thromboembolism (blood clots), severe infections due to immune suppression, hepatotoxicity (liver damage), peripheral neuropathy (tingling or numbness in hands and feet), tumor lysis syndrome, or severe allergic reactions including Stevens-Johnson syndrome. Seek immediate medical attention if you experience chest pain, shortness of breath, sudden leg swelling, jaundice, or any other severe or unusual symptom.

Drug interaction

Lenalidomide may interact with anticoagulants and antiplatelet agents (increasing bleeding risk), certain chemotherapy drugs, immunosuppressants, erythropoiesis-stimulating agents, and medications that are primarily excreted through the kidneys. Digoxin levels should be monitored when used concurrently with lenalidomide. Inform your oncologist about all prescription medications, over-the-counter drugs, vitamins, and herbal supplements you are taking to prevent potentially dangerous interactions.

Missed dose

If you miss a dose of lenalidomide, take it as soon as you remember on the same day. If it is already the next day or close to the time of your next scheduled dose, skip the missed dose entirely and resume your normal dosing schedule. Never take two doses at once to make up for a missed one. Contact your healthcare provider if you are unsure about what to do.

Overdose

An overdose of lenalidomide may lead to dangerously low blood cell counts (severe pancytopenia), a heightened risk of life-threatening infections, organ toxicity, or other serious complications. There is no specific antidote for lenalidomide overdose. If you suspect an overdose, seek emergency medical attention immediately. Supportive care, including blood transfusions and infection management, may be required.

Storage

Store lenalidomide capsules at room temperature between 20 and 25 degrees Celsius, protected from moisture and heat. Keep the capsules in the original container with the lid tightly closed and out of the reach of children and pets. Do not transfer capsules to other containers. Handle with care, as the drug is hazardous; avoid direct skin contact with broken or opened capsules.

Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.